<DOC>
	<DOCNO>NCT02469922</DOCNO>
	<brief_summary>Open multicentric study assess predictive value 18-FDG PET ( SUV max ) 20 Gy radio-chemotherapy , loco-regional control 2 year</brief_summary>
	<brief_title>Positron Emission Tomography ( PET ) During Radio-chemotherapy Treat Otorhinolaryngological Cancer</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<criteria>Age ≥ 18 year ≤ 75 year invasive epidermoid carcinoma head neck ( exclude nasopharyngeal ) , confirm histology locally advanced disease ( nonmetastatic stage AJCC IIIIV ) . AJCC = American Joint Committee Cancer performance status ECOG ≤ 2 . ECOG = Eastern Cooperative Oncology Group history irradiation head neck start radiotherapy within 8 week pretreatment PET Scan surgery biopsy pregnancy test : negative woman childbearing potential reliable contraception childbearing couple , men woman must reliable contraception treatment sign informed consent form patient national health insurance prior radiotherapy chemotherapy history cancer except : cutaneous nonmelanoma tumor cervix situ carcinoma unstable condition ( cardiovascular , renal , pulmonary ) systemic ( lupus erythematosus , scleroderma ) pregnant patient patient breastfeed patient unable give consent patient administrative supervision patient participate another clinical trial experimental drug regular followup impossible various reason ( familial , economical , social , ... ) diabetes accelerated radiotherapy protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>